PFSA
Profusa, Inc.Company Information
- Company Name
- Profusa, Inc.
- CIK
- CIK0001859807
- Category
- <br>Emerging growth company
- Ticker: Exchange
- PFSA: Nasdaq, NVACW: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- PFSA
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-12
- Last sale
- 2026-08-17
- Shares purchased (TTM)
- 22,016
- Shares sold (TTM)
- 67,173
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 46,663
- Shares outstanding
- 57,676
- Ownership
- 80.91%
Earnings Market Reaction
- Filing date
- 2026-08-19
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | 3 | 0 | 0 | -28 | 26 | 2 | 25 | 0 | 0 | 1 | 1 | 0 | ||||||
| Series A Preferred Stock | - | - | 0 | -4 | - | 4 | 0 | 4 | - | - | - | - | ||||||
| Series B Preferred Stock | - | - | 0 | -5 | - | 5 | 0 | 5 | - | - | - | - | ||||||
| Series C Preferred Stock | - | - | 0 | -8 | - | 8 | 0 | 8 | - | - | - | - | ||||||
| Undesignated Preferred Stock | - | - | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Cash | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 0 | 2 | 3 | 0 | - | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Restricted Cash Current | - | - | - | - | 0 | 0 | - | - | - | - | - | - | ||||||
| Assets Held In Trust Current | - | - | - | - | 1 | - | - | 1 | - | - | 2 | - | ||||||
| Prepaid Taxes | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 1 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Held In Trust | - | - | - | - | - | - | - | - | - | - | 2 | - | ||||||
| Crypto Asset Fair Value Current | - | - | 1 | 1 | - | - | - | - | - | - | - | - | ||||||
| Assets Current | 1 | 1 | 4 | 4 | 1 | 0 | 0 | 1 | 0 | 0 | 2 | 0 | ||||||
| Assets Held In Trust Noncurrent | - | - | - | - | 1 | 2 | 8 | 8 | 8 | 8 | 9 | 11 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Deferred Costs | 0 | 0 | - | - | - | - | 3 | - | - | - | - | - | ||||||
| Assets | 1 | 1 | 4 | 4 | 2 | 2 | 3 | 9 | 9 | 8 | 11 | 11 | ||||||
| Other Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | - | 2 | 1 | 1 | 1 | ||||||
| Redeemable Noncontrolling Interest Equity Common Carrying Amount | - | - | - | - | - | - | - | 1 | - | - | 2 | - | ||||||
| Accounts Payable Current | 8 | 8 | 7 | 7 | - | - | 5 | - | - | - | - | - | ||||||
| Sales And Excise Tax Payable Current | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Accrued Income Taxes Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Redeemable Noncontrolling Interest Equity Common Redemption Value | - | - | - | - | 1 | - | - | - | - | - | - | - | ||||||
| Accrued Liabilities Current | 6 | 6 | 6 | 8 | 2 | 1 | 4 | 1 | 1 | 1 | 0 | - | ||||||
| Convertible Debt Current | 8 | 7 | 4 | 4 | - | - | 46 | - | - | - | - | - | ||||||
| Notes Payable Current | 1 | 1 | 1 | 1 | - | - | 1 | - | - | - | - | - | ||||||
| Other Loans Payable Current | - | - | 1 | 1 | - | - | 1 | - | - | - | - | - | ||||||
Convertible Longterm Notes Payable Current And Noncurrent | ||||||||||||||||||
| Liabilities Current | 28 | 29 | 22 | 24 | 16 | 13 | 57 | 5 | 4 | 4 | 5 | 3 | ||||||
| Deferred Income Tax Liabilities Net | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Warrants And Rights Outstanding | 0 | 0 | 0 | 0 | 7 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | ||||||
| Liabilities | 28 | 29 | 30 | 38 | 23 | 14 | 57 | 6 | 5 | 5 | 5 | 4 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | 1 | 2 | 8 | 8 | 9 | 8 | 9 | 11 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Features Of Convertible Preferred Stock | ||||||||||||||||||
| Additional Paid In Capital | 146 | 136 | 134 | 118 | - | - | 6 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -173 | -164 | -161 | -152 | -23 | -14 | -125 | -5 | -5 | -4 | -3 | -3 | ||||||
| Stockholders Equity | -27 | -28 | -27 | -34 | -124 | -122 | -119 | -117 | -5 | -4 | -3 | -3 | ||||||
| Liabilities And Stockholders Equity | 1 | 1 | 4 | 4 | 2 | 2 | 3 | 9 | 9 | 8 | 11 | 11 | ||||||
| Temporary Equity Shares Issued | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | - | - | - | - | - | - | 65 | - | - | - | - | - | ||||||
| Temporary Equity Redemption Price Per Share | - | - | - | - | 13.07 | 12.83 | 12.13 | 11.84 | 11.59 | 11.34 | 11.10 | 10.90 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 600 | 600 | 600 | 600 | 100 | 100 | 600 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 0 | 2 | 1 | 42 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 0 | 2 | 1 | 42 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Notes Payable | - | 2 | - | - | - | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialProfusa, Inc. (PFSA) — SEC Financial Statements & Analysis
Profusa, Inc. (PFSA) is a surgical & medical instruments & apparatus company, incorporated in DE. Profusa, Inc. trades on Nasdaq, OTC as: PFSA, NVACW. Profusa, Inc. (PFSA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on that filing, Profusa, Inc. carries a market cap of $674.81K, a P/E ratio of -0.02x, a P/B ratio of -0.02x, a P/S ratio of 2827242.61x, an enterprise value of $8.81M, and an EV/EBITDA multiple of -0.28x. On profitability, it posts an operating margin of -107236.12%, a net margin of -131084.94%, a Return on Equity (ROE) of 56.80%, and a Return on Assets (ROA) of -2860.46%. Per share, it reports EPS of $-745.02, diluted EPS of $-745.02, free cash flow per share of $-353.84, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 228.61% year-over-year, and EPS growth of -98.53% year-over-year. On the balance sheet, it maintains a current ratio of 0.03x, a quick ratio of 0.03x, working capital of $-27.33M, a debt-to-equity ratio of -1.04x, a debt ratio of 27.03, an interest coverage ratio of -137.20x, free cash flow of $-20.41M (TTM), and net debt of $8.13M. Figures sourced from SEC EDGAR.
- Market Cap
- $674.81K
- P/E TTM
- -0.02x
- EPS TTM
- $-745.02
- P/B TTM
- -0.02x
- ROE TTM
- 56.80%
- ROA TTM
- -2860.46%
- Debt To Equity
- -1.04x
- Free Cash Flow TTM
- $-20.41M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Profusa, Inc. in?
Profusa, Inc. (PFSA) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does PFSA trade on?
Profusa, Inc. (PFSA) trades on the Nasdaq, OTC.
Where is Profusa, Inc. incorporated?
Profusa, Inc. is incorporated in DE.
When was Profusa, Inc. (PFSA)'s most recent SEC filing?
Profusa, Inc. (PFSA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19.
What is PFSA's market cap?
Profusa, Inc. (PFSA) has a market capitalization of $674.81K as of 2026-06-30.
What is PFSA's EPS (earnings per share)?
Profusa, Inc. (PFSA)'s trailing twelve month EPS is $-745.02 as of 2026-06-30.
What is PFSA's ROE (return on equity)?
Profusa, Inc. (PFSA)'s trailing twelve month Return on Equity (ROE) is 56.80% as of 2026-06-30.
What is PFSA's ROA (return on assets)?
Profusa, Inc. (PFSA)'s trailing twelve month Return on Assets (ROA) is -2860.46% as of 2026-06-30.
What is PFSA's EV/EBITDA?
Profusa, Inc. (PFSA)'s trailing twelve month EV/EBITDA is -0.28x as of 2026-06-30.